More information
| Project name | Acceleration of bridge-building between basic research and clinical research - acceleration for attainment of individual medical care for cancer patient and anticancer agent development utilizing gene expression analysis technology - |
|---|---|
| Area | Biotechnologyć»Medical technology |
| Purpose | This project serves as an intermediary between basic research results with originally developed gene expression analysis technology and cancer clinicals / anticancer agent development field. |
| Introduction | R&D theme: 1. Identification of anticancer agent susceptibility gene cluster with cell strain. 2. Validation of effectiveness for anticancer agent susceptibility gene cluster with clinical cancer samples. 3. Identification of potential drug target gene by analysing of gene expression information. |
| Keyword | anticancer agent susceptibility gene cluster | clinical cancer samples | gene expression information |
| Started fiscal year | 2009-2012 |
| Project head | Under investigation |
| Institute of the head | Under investigation |
| Budget (million yen) | Under investigation |
| Representative Institute of the commission | New Energy and Industrial Technology Development Organization (NEDO) |
| Companies | Japan Biological Informatics Consortium (JBiC) | NIPPON GENE CO., LTD. | Astellas Pharma Inc. | Taiho Pharmaceutical Co., Ltd. | DAIICHI SANKYO CO., LTD. | Kyowa Hakko Kirin Co., Ltd. | ONO PHARMACEUTICAL CO., LTD. |
| Published papers (PubMed IDs) | 18374459 | 18492486 | 18619509 | 19054851 |
| Patent (Japan, overseas) | Under investigation |
Product (Database, Tool)
Nothing
Relating project
Nothing